Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01491971 | Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer(IM1) | completed | Phase 2 | 76 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 12, 2013 | clinicaltrials |
| NCT00510224 | Sandostatin for Patients With Androgen Independent Prostate Cancer | terminated | Phase 2 | 13 | University of California, San FranciscoOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00684970 | Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)(TLH-202) | unknown | Phase 2 | 100 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01938339 | Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer | unknown | N/A | 60 | Seoul National University HospitalOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT02001571 | A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function | completed | Phase 1 | 24 | Cougar Biotechnology, Inc.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT02001597 | Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy(TRUS-RP) | completed | — | 20 | University of British ColumbiaOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00003183 | Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 64 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003290 | Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 2 | Dec 4, 2013 | clinicaltrials |
| NCT00005960 | Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00181597 | Trilostane for Androgen-Independent Prostate Cancer | completed | Phase 2 | 24 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Dec 3, 2013 | clinicaltrials |
| NCT01487720 | GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer | completed | Phase 2 | 33 | Asan Medical CenterOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT01584960 | The Effect of Endurance Training in Patients With Prostate Cancer | completed | N/A | 30 | Inge HolmOTHER | 1 | Dec 2, 2013 | clinicaltrials |
| NCT00681148 | Botulinum Toxin Injection With Prostate Brachytherapy | withdrawn | Phase 2 | 0 | Emory UniversityOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT00086736 | Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy | completed | Phase 2 | 34 | University of Alabama at BirminghamOTHER | 1 | Nov 19, 2013 | clinicaltrials |
| NCT00945477 | Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade | terminated | Phase 2 | 11 | Illinois CancerCare, P.C.OTHER | 1 | Nov 18, 2013 | clinicaltrials |
| NCT00129142 | Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy | completed | Phase 3 | 1,200 | GTxINDUSTRY | 2 | Nov 15, 2013 | clinicaltrials |
| NCT01414296 | Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer | completed | Phase 1 | 10 | Progenics Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01423006 | Pilot Study on Focal Prostate Radio-Frequency Ablation | completed | N/A | 5 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT00884273 | Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients | completed | Phase 3 | 182 | Ferring PharmaceuticalsINDUSTRY | 8 | Nov 13, 2013 | clinicaltrials |
| NCT00831233 | Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer | terminated | Phase 3 | 42 | Ferring PharmaceuticalsINDUSTRY | 3 | Nov 11, 2013 | clinicaltrials |
| NCT01617174 | Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Nov 8, 2013 | clinicaltrials |
| NCT00002703 | Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | completed | Phase 3 | 390 | Proton Radiation Oncology GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005075 | Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer | terminated | Phase 3 | — | EDAP TechnomedINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005939 | Brachytherapy in Treating Patients With Recurrent Prostate Cancer | unknown | Phase 1 / Phase 2 | — | Center for Molecular MedicineOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00054015 | 3-AP in Treating Patients With Advanced Prostate Cancer | completed | Phase 2 | — | Vion PharmaceuticalsINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00348998 | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | unknown | Phase 2 | 18 | Virginia Mason Hospital/Medical CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00814892 | Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer | terminated | Phase 2 | 2 | Mayo ClinicOTHER | 1 | Nov 5, 2013 | clinicaltrials |
| NCT01414283 | Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer | completed | Phase 1 | 52 | Progenics Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 1, 2013 | clinicaltrials |
| NCT00132522 | EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide | completed | Phase 1 | 45 | EMD SeronoINDUSTRY | 2 | Oct 25, 2013 | clinicaltrials |
| NCT01964638 | Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis. | completed | N/A | 126 | NYU Langone HealthOTHER | 1 | Oct 17, 2013 | clinicaltrials |
| NCT00003903 | Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer | completed | N/A | 150 | University of RochesterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01481233 | Oral Colchicine in Men With Castrate Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Milton S. Hershey Medical CenterOTHER | 0 | Sep 27, 2013 | clinicaltrials |
| NCT00009750 | Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 1 | — | University of California, DavisOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00020995 | Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00322114 | Lycopene in Preventing Prostate Cancer in Healthy Participants | unknown | N/A | 150 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00354497 | Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men | unknown | Phase 2 | 800 | Lawrence Livermore National Laboratory at University of CaliforniaOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00416390 | Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia | completed | N/A | 120 | University of Illinois at ChicagoOTHER | 0 | Sep 20, 2013 | clinicaltrials |
| NCT00765479 | Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer | completed | Phase 2 / Phase 3 | 284 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00503646 | Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners | unknown | N/A | 100 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01486563 | Hydroxyethyl Starch and Renal Function After Radical Prostatectomy(VORA) | completed | Phase 4 | 40 | Regional Hospital HolstebroOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01937585 | Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men | completed | N/A | 231 | Fox Chase Cancer CenterOTHER | 1 | Sep 9, 2013 | clinicaltrials |
| NCT01161563 | Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration | completed | Phase 4 | 118 | Watson PharmaceuticalsINDUSTRY | 1 | Sep 6, 2013 | clinicaltrials |
| NCT00006002 | SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 36 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00026377 | SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | 3 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00363285 | Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer | unknown | Phase 3 | 900 | St. Bartholomew's HospitalOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00376792 | Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | unknown | Phase 3 | 396 | Scandinavian Prostate Cancer GroupNETWORK | 5 | Aug 26, 2013 | clinicaltrials |
| NCT00561262 | High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 60 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00561314 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 33 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Dec 12, 2013source: clinicaltrials